Shi et al. (Shi et al., 2021) reported that ABCD1 (an ATP-binding cassette transporter of fatty acids) is a key downstream target of METTL3 in RCC, and the knockdown of ABCD1 in RCC cells decreased cancer cell migration and spheroid formation. Here, ABCD1 is linked to renal cell adenocarcinoma.